Summit Global Investments’s Phibro Animal Health PAHC Stock Holding History

Summit Global Investments’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-37,989	Closed	-$811K	–	509
2025 Q1	$811K	Buy	37,989 +10,808	+40%	+$242K	0.06%	203
2024 Q4	$571K	Buy	+27,181	New	+$629K	0.04%	330
2019 Q3	–	Sell	-25,700	Closed	-$816K	–	291
2019 Q2	$816K	Buy	25,700 +2,200	+9%	+$69K	0.1%	125
2019 Q1	$776K	Buy	+23,500	New	+$731K	0.1%	128
2018 Q4	–	Sell	-14,500	Closed	-$622K	–	298
2018 Q3	$622K	Hold	14,500	–	–	0.08%	230
2018 Q2	$668K	Sell	14,500 -900	-6%	-$39.8K	0.1%	173
2018 Q1	$611K	Sell	15,400 -200	-1%	-$7.41K	0.1%	134
2017 Q4	$523K	Buy	+15,600	New	+$554K	0.08%	225

Other funds holding PAHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Summit Global Investments's PAHC Position: Q2 2025 in Review

Summit Global Investments sold out of Phibro Animal Health (PAHC) in Q2 2025, closing a stake of 37,989 shares — an estimated $811K sold.

Summit Global Investments first reported a position in PAHC in Q4 2017 and held it in 8 quarters. The position peaked at $816K in Q2 2019. 194 funds tracked by Wall St. Rank hold PAHC as of Q2 2025.

Summit Global Investments reported no remaining Phibro Animal Health position as of Q2 2025 after selling out during the quarter.
Summit Global Investments sold 37,989 Phibro Animal Health shares in Q2 2025, an estimated $811K.
Summit Global Investments first reported a position in Phibro Animal Health in Q4 2017 and held it in 8 quarters.
Summit Global Investments's Phibro Animal Health position peaked at $816K in Q2 2019.
194 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2025.

Based on Summit Global Investments's 13F filing for Q2 2025, filed 12 Aug 2025.